RxDoctor Payments Data

Brett Blaser, DO

Family Medicine · Ogden, UTNPI 1538471313

Payments from drug & device makers

$12,381in general payments, 2019–2025

Across 67 payments — averaging $184.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$12K
  • Shire North American Group Inc$173
  • Astellas Pharma US Inc$158
  • Avanir Pharmaceuticals, Inc.$69
  • AbbVie$68
  • Supernus Pharmaceuticals, Inc.$63
  • plus $304 from 14 others

What the payments were for

  • Consulting fees$11,50593%
  • Food & beverage$7766%
  • Education$1001%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,381 in reported general payments places this provider in the 90th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$3,913
Medicare patients
12
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$10,518
MyrbetriqMirabegron19$7,878
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$2,510
Oxycodone Hcl91$2,190
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$1,623
Theophylline ErTheophylline Anhydrous11$1,519
Duloxetine Hcl15$864
Donepezil Hcl16$709
Gabapentin55$682
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine34$664
Albuterol Sulfate HfaAlbuterol Sulfate21$602
Omeprazole38$461
Ondansetron OdtOndansetron14$433
Memantine Hcl ErMemantine Hcl13$396
Olanzapine13$388

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$10,51817 claims
Astellas Pharma US IncMyrbetriq$158$7,87819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 928 family medicine providers in Utah.

Other family medicine in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →